Cargando…

Timing of Antiretroviral Therapy for HIV in the Setting of TB Treatment

The convergent human immunodeficiency virus (HIV) and tuberculosis (TB) pandemics continue to collectively exact significant morbidity and mortality worldwide. Highly active antiretroviral therapy (HAART) has been a critical component in combating the scourge of these two conditions as both a preemp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piggott, Damani A., Karakousis, Petros C.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017895/ https://www.ncbi.nlm.nih.gov/pubmed/21234380 http://dx.doi.org/10.1155/2011/103917

Ejemplares similares

Effects of time of initiation of antiretroviral therapy in the treatment of patients with HIV/TB co-infection: A systemic review and meta-analysis
por: Chelkeba, Legese, et al.
Publicado: (2020)

Do common mental disorders decline over time in TB/HIV co-infected and HIV patients without TB who are on antiretroviral treatment?
por: Deribew, Amare, et al.
Publicado: (2013)

TB testing in HIV-positive patients prior to antiretroviral treatment
por: Spooner, E., et al.
Publicado: (2022)

Antiretroviral Therapy in Prevention of HIV and TB: Update on Current Research Efforts
por: Granich, Reuben, et al.
Publicado: (2011)

Delay in the Provision of Antiretroviral Therapy to HIV-infected TB Patients in Nigeria
por: Odume, B., et al.
Publicado: (2017)

Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India
por: Isaakidis, Petros, et al.
Publicado: (2012)

Predictors of early mortality and effectiveness of antiretroviral therapy in TB-HIV patients from Brazil
por: Demitto, Fernanda O., et al.
Publicado: (2019)

The Effect of Complete Integration of HIV and TB Services on Time to Initiation of Antiretroviral Therapy: A Before-After Study
por: Kerschberger, Bernhard, et al.
Publicado: (2012)

Comment on: Effects of time of initiation of antiretroviral therapy in the treatment of patients with HIV/TB co-infection, by Chelkeba L. et al
por: Blanc, François-Xavier, et al.
Publicado: (2020)

HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?
por: Kulpa, Deanna A, et al.
Publicado: (2015)

Linking HIV-Infected TB Patients to Cotrimoxazole Prophylaxis and Antiretroviral Treatment in India
por: Raizada, Neeraj, et al.
Publicado: (2009)

The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis
por: Dodd, P J, et al.
Publicado: (2017)

HIV-TB coinfection: Clinico-epidemiological determinants at an antiretroviral therapy center in Southern India
por: Kamath, Ramachandra, et al.
Publicado: (2013)

HIV/Tuberculosis Coinfection in Pregnancy and the Postpartum Period
por: Yilma, Addis, et al.
Publicado: (2023)

Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy
por: Suwanpimolkul, Gompol, et al.
Publicado: (2022)

Integrase inhibitors versus efavirenz combination antiretroviral therapies for TB/HIV coinfection: a meta-analysis of randomized controlled trials
por: Shu, Yuanlu, et al.
Publicado: (2021)

Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings
por: Peterson, Kevin, et al.
Publicado: (2011)

Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIV
por: Tabarsi, Payam, et al.
Publicado: (2009)

Reply to “At the crossroads between early or delayed antiretroviral therapy initiation during TB/HIV coinfection”
por: Saraceni, Valeria, et al.
Publicado: (2014)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
por: Dubrocq, Gueorgui, et al.
Publicado: (2018)

Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review
por: Jacobs, Tom G, et al.
Publicado: (2020)

The antiretroviral efficacy of highly active antiretroviral therapy and plasma nevirapine concentrations in HIV-TB co-infected Indian patients receiving rifampicin based antituberculosis treatment
por: Sinha, Sanjeev, et al.
Publicado: (2011)

New Antiretroviral Treatment for HIV
por: Badowski, Melissa E., et al.
Publicado: (2016)

Immune Phenotype and Functionality of Mtb-Specific T-Cells in HIV/TB Co-Infected Patients on Antiretroviral Treatment
por: Mupfumi, Lucy, et al.
Publicado: (2020)

Antiretroviral Treatment Scale-Up and Tuberculosis Mortality in High TB/HIV Burden Countries: An Econometric Analysis
por: Yan, Isabel, et al.
Publicado: (2016)

Provision of Antiretroviral Therapy for HIV-Positive TB Patients — 19 Countries, Sub-Saharan Africa, 2009–2013
por: Dokubo, E. Kainne, et al.
Publicado: (2014)

Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country?
por: Benzaken, Adele S., et al.
Publicado: (2019)

HIV screening among TB patients and level of antiretroviral therapy and co-trimoxazole preventive therapy for TB/HIV patients in Hawassa University Referral Hospital: a five year retrospective study
por: Simieneh, Asnake, et al.
Publicado: (2017)

High uptake of antiretroviral therapy among HIV-positive TB patients receiving co-located services in Swaziland
por: Pathmanathan, Ishani, et al.
Publicado: (2018)

Treatment outcomes and factors associated with mortality among individuals with both TB and HIV in the antiretroviral era in Thailand
por: Gatechompol, Sivaporn, et al.
Publicado: (2019)

HIV and urethritis: time required for antiretroviral therapy to suppress HIV in semen
por: Matoga, Mitch, et al.
Publicado: (2023)

LB19. Intramuscular therapeutic immunization targeting Rel(Mtb)/MIP-3 induces immune signatures associated with better TB control in vivo compared to
por: Karanika, Styliani, et al.
Publicado: (2021)

Long-acting injectable antiretroviral therapy: will it change the future of HIV treatment?
por: Brizzi, Marisa, et al.
Publicado: (2023)

Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination
por: Chuang, Yu-Min, et al.
Publicado: (2020)

Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability
por: Kimmel, April D, et al.
Publicado: (2012)

Assessment at Antiretroviral Clinics during TB Treatment Reduces Loss to Follow-Up among HIV-Infected Patients
por: Pepper, Dominique J., et al.
Publicado: (2012)

Real-Time Adherence Monitoring for HIV Antiretroviral Therapy
por: Haberer, Jessica E., et al.
Publicado: (2010)

Assessing the impact of TB/HIV services integration on TB treatment outcomes and their relevance in TB/HIV monitoring in Ghana
por: Ansa, Gloria Akosua, et al.
Publicado: (2012)

Enfuvirtide antiretroviral therapy in HIV-1 infection
por: Kitchen, Christina MR, et al.
Publicado: (2008)

HIV Is Associated with Modified Humoral Immune Responses in the Setting of HIV/TB Coinfection
por: van Woudenbergh, Esther, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rhorn7pitq6dln0ojk5i5434ba